Research library
Sources, with the status on the record.
Each row is a paper or a ClinicalTrials.gov entry checked on 21 November 2026. Titles are the authors’ or the registry’s words. Nalen Lab does not restate them as claims about these products. A registration is not a result.
Records checked 2026-11-21. Open registry rows in this view: 3. Selank has published papers and no verified intervention trial.
Loading filters…
GHK-Cu
2018
Publication
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.
Pickart L et al. · International Journal of Molecular Sciences
PublishedSame compound as the catalogue listing
Review. The title is the authors' wording.
View in the catalogueGHK-Cu
2015
Publication
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.
Pickart L et al. · BioMed Research International
PublishedSame compound as the catalogue listing
Review.
View in the catalogueGHK-Cu
2012
Publication
The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.
Pickart L et al. · Oxidative Medicine and Cellular Longevity
PublishedSame compound as the catalogue listing
Review.
View in the catalogueGHK-Cu
2026
Registry
Topical GHK-Cu Gel for Acute Skin Wound Healing
Phase 2 · ClinicalTrials.gov · NCT07437586 · Hudson Biotech
RecruitingSame compound as the catalogue listing
Topical gel, not a lyophilised vial. Checked 21 November 2026.
View in the catalogueGHK-Cu
2026
Registry
Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults
Not applicable · ClinicalTrials.gov · NCT07706361 · LifeWave, Inc.
Not yet recruitingMeasures or combines the compound; not a single-compound vial study
The intervention is a patch. The record measures circulating GHK and GHK-Cu. It does not administer a GHK-Cu vial.
View in the catalogueGHK-Cu
2026
Registry
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
Early phase 1 · ClinicalTrials.gov · NCT07888595 · Frontiers in Bioscience Research Institute and Aging
Enrolling by invitationMeasures or combines the compound; not a single-compound vial study
One record covers several agents. The topical serum is described as containing GHK-Cu, AHK-Cu, Epitalon, PGP and CLV, alongside other agents taken by mouth or injection. Not a GHK-Cu-only trial. Also listed under Epitalon.
View in the catalogue